Evidence map›Paper›PMID 26211808›Full record

ArticleBritish journal of pharmacology2015

δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine.

Felicia Klinger, Mirnes Bajric, Isabella Salzer, Mario M Dorostkar, Deeba Khan, Daniela D Pollak, Helmut Kubista, Stefan Boehm, Xaver Koenig

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Antinociceptive activity of doliroside B.Pharmaceutical biology · 2023
    Article
  4. Flupirtine enhances NHE-3-mediated NaAmerican journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  5. The KNeuroscience · 2021
    Article
  6. Chemical modulation of Kv7 potassium channels.RSC medicinal chemistry · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Breaking barriers to novel analgesic drug development.Nature reviews. Drug discovery · 2017
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Felicia KlingerDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Mirnes BajricDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Isabella SalzerDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Mario M DorostkarDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Deeba KhanDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Daniela D PollakDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Helmut KubistaDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Stefan BoehmDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Xaver KoenigDepartment of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria.
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF P 23658
6 · The paper itself

Abstract

background and purposeThe Kv 7 channel activator flupirtine is a clinical analgesic characterized as 'selective neuronal potassium channel opener'. Flupirtine was found to exert comparable actions at GABAA receptors and Kv 7 channels in neurons of pain pathways, but not in hippocampus. EXPERIMENTAL APPROACH: Expression patterns of GABAA receptors were explored in immunoblots of rat dorsal root ganglia, dorsal horns and hippocampi using antibodies for 10 different subunits. Effects of flupirtine on recombinant and native GABAA receptors were investigated in patch clamp experiments and compared with the actions on Kv 7 channels. KEY

resultsImmunoblots pointed towards α2, α3, β3 and γ2 subunits as targets, but in all γ2-containing receptors the effects of flupirtine were alike: leftward shift of GABA concentration-response curves and diminished maximal amplitudes. After replacement of γ2S by δ, flupirtine increased maximal amplitudes. Currents through α1β2δ receptors were more enhanced than those through Kv 7 channels. In hippocampal neurons, flupirtine prolonged inhibitory postsynaptic currents, left miniature inhibitory postsynaptic currents (mIPSCs) unaltered and increased bicuculline-sensitive tonic currents; penicillin abolished mIPSCs, but not tonic currents; concentration-response curves for GABA-induced currents were shifted to the left by flupirtine without changes in maximal amplitudes; in the presence of penicillin, maximal amplitudes were increased; GABA-induced currents in the presence of penicillin were more sensitive towards flupirtine than K(+) currents. In dorsal horn neurons, currents evoked by the δ-preferring agonist THIP (gaboxadol) were more sensitive towards flupirtine than K(+) currents. CONCLUSIONS AND IMPLICATIONS: Flupirtine prefers δ-containing GABAA receptors over γ-containing ones and over Kv 7 channels.

Indexed as

AminopyridinesAnalgesicsAnimalsCell LineCells, CulturedGanglia, SpinalHippocampusHumansInhibitory Postsynaptic PotentialsKCNQ Potassium ChannelsNeuronsRatsReceptors, GABA-ASpinal Cord Dorsal HornAminopyridinesAnalgesicsflupirtineKCNQ Potassium ChannelsReceptors, GABA-A

Identifiers

PMID26211808
PMCPMC4621994
OpenAlexW1602151323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.